US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY HEALTH CARE ETF

38.53

+0.96702.57%

Post-market: 38.530.00000.00%19:30 EDT

Volume:66.22K

Turnover:2.53M

Market Cap:319.77M

PE:- -

High:38.63

Open:37.81

Low:37.81

Close:37.56

52wk High:40.63

52wk Low:32.03

Shares:8.30M

Float Shares:8.30M

Volume Ratio:0.34

T/O Rate:0.80%

Dividend:0.30

Dividend Rate:0.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Teva announces FDA approval for Weltruza

Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak

Health Care Down as Michigan Files Suit Against Insurer

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

Adherium Secures Non-Dilutive AUD$700,000 Loan to Support Working Capital

Perimeter Medical Imaging AI Adds Veteran CFO Michelle Caron to Board Amid Commercial Expansion

Press Release: Perimeter Medical Imaging AI Appoints Finance Executive Michelle Caron to Board of Directors

2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

EBR Systems advances FDA approval process for new WiSE manufacturing site

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

Lucid Diagnostics advances Medicare reimbursement and coding infrastructure

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Weight-Loss Drug Giant Sheds 13,000 Positions

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

Ultragenyx price target raised to $35 from $32 at Barclays

Health Advisory: Avoid Misusing Weight-Loss Medications, Prioritize Evaluation Before Treatment

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/PINK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PINK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PINK\",,,,,undefined,":{"symbol":"PINK","market":"US","secType":"STK","nameCN":"SIMPLIFY HEALTH CARE ETF","latestPrice":38.527,"timestamp":1791576000000,"preClose":37.56,"halted":0,"volume":66222,"hourTrading":{"tag":"盘后","latestPrice":38.527,"preClose":38.527,"latestTime":"19:30 EDT","volume":13,"amount":500.897,"timestamp":1791588606707,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02574547390841317,"floatShares":8300001,"shares":8300001,"eps":0,"marketStatus":"Market Closed","change":0.967,"latestTime":"10-09 16:00:00 EDT","open":37.81,"high":38.63,"low":37.81,"amount":2531996.448228,"amplitude":0.021832,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":37.56,"sharesOutstanding":7975001,"nav":37.6065,"aum":312122036.32,"dividendRate":0.0078,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":37.71,"preClose":37.56,"latestTime":"06:39 EDT","volume":1230,"amount":46408.101720000006,"timestamp":1791542368458,"change":0.15,"changeRate":0.003994,"amplitude":0.003727},"postHourTrading":{"tag":"盘后","latestPrice":38.527,"preClose":38.527,"latestTime":"19:30 EDT","volume":13,"amount":500.897,"timestamp":1791588606707,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.339700690681725,"impliedVol":0.167,"impliedVolPercentile":0.9323},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PINK\",,,,,undefined,":{"symbol":"PINK","floatShares":8300001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.339700690681725,"shares":8300001,"dividePrice":0.3005,"high":38.63,"amplitude":0.021832,"preClose":37.56,"low":37.81,"week52Low":32.03,"pbRate":"--","week52High":40.63,"institutionHeld":0,"latestPrice":38.527,"eps":0,"divideRate":0.0078,"volume":66222,"delay":0,"ttmEps":0,"open":37.81,"prevYearClose":36.6,"prevWeekClose":38.13,"prevMonthClose":38.6,"prevQuarterClose":38.6,"fiveDayClose":38.13,"twentyDayClose":38.69,"sixtyDayClose":38.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PINK\",params:#limit:5,,,undefined,":[{"date":"2026-09-25","symbol":"PINK","amount":0.1,"announcedDate":"2026-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-25","defaultRemindTime":1790343000000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-25","currency":"USD","dateTimestamp":1790308800000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"PINK","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"PINK","amount":0.05,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-09-25","symbol":"PINK","amount":0.05,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"PINK","amount":0.05,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"SIMPLIFY HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PINK\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-27","recordDate":"2021-12-28","paymentDate":"2021-12-30","value":0.0117,"currency":"USD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-03-31","value":0.03535,"currency":"USD"},{"executeDate":"2022-06-27","recordDate":"2022-06-28","paymentDate":"2022-06-30","value":0.02945,"currency":"USD"},{"executeDate":"2022-09-27","recordDate":"2022-09-28","paymentDate":"2022-09-30","value":0.03121,"currency":"USD"},{"executeDate":"2022-12-27","recordDate":"2022-12-28","paymentDate":"2022-12-30","value":0.01698,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PINK\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PINK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674785642","title":"Teva announces FDA approval for Weltruza","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785642?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543924,"startTime":"0","endTime":"0","summary":"Teva (TEVA) announced that the FDA has approved Weltruza for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","LABU","XLVX","GDOC","GNMX","FRTY","BMED","BK4007","IEIH","MRNY","MRNX","BBP","BK4584","LU1983299246.USD","RSPH","IYH","BK4588","BK4559","IBB","LFSC","PINK","SYNB","IDNA","NVIB","TBXU","BK4596","LU2324357040.USD","PSCH","TECB","MEDI","BK4585","BK4566","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118774782","title":"Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak","url":"https://stock-news.laohu8.com/highlight/detail?id=1118774782","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118774782?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:30","pubTimestamp":1791527422,"startTime":"0","endTime":"0","summary":"Citi has cut its price target on Danish pharmaceutical company Novo Nordisk from DKK 310 to DKK 296, while maintaining a \"Neutral\" rating.The main reason is that Novo Nordisk expects its profit...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","C","BK4534","IYH","LU2456880835.USD","IYF","LU0130517989.USD","LU0130102774.USD","LU0648001328.SGD","BK4504","LU0170899867.USD","LU0980610538.SGD","LU1244550577.SGD","BK4588","LU1366192091.USD","LU1506573853.SGD","LU2236285917.USD","LU2462157665.USD","NVOH","LU0314106906.USD","TRUH","LU2125154778.USD","LU0128525689.USD","LU2417539215.USD","PINK","MEDI","BK4585","CURE","LU0310800965.SGD","BK4207","BK4559","XLVI","BGIA","IE00BSNM7G36.USD","PJP","FXH","LU1201861249.SGD","LU0477156953.USD","LU1668664300.SGD","LU0072461881.USD","LU1267930227.SGD","LU0052756011.USD","LU2360032135.SGD","LU1162221912.USD","LU2125154935.USD","LU0098860793.USD","LU0203345920.USD","FTXO","RSPH","LU1791807156.HKD","NVOX","TFNS","NBDS","BK4566","NVOC","THNR","LU1144417596.USD","LU0320765646.SGD","LU0162691827.USD","LU1074936037.SGD","LU1244550494.USD","LU1244550221.USD","FHLC","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674880548","title":"Health Care Down as Michigan Files Suit Against Insurer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674880548","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674880548?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:28","pubTimestamp":1791494880,"startTime":"0","endTime":"0","summary":"Health-care companies fell amid fears that health insurers would remain in regulatory crosshairs during the election season.Michigan's attorney general filed an antitrust suit against the state's largest health insurer Blue Cross Blue Shield of Michigan, citing monopolistic pricing practices.Among publicly traded health insurers, Humana and UnitedHealth Group lost ground.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0211328371.USD","JDOC","PINK","IXJ","JHMH","LU0011850046.USD","RXL","UN","IE00B894F039.SGD","GDOC","IE0002141913.USD","SUNH0main","FXH","VHT","LU0162691827.USD","LABU","XLV","CURE","IE00B2B36J28.USD","SG9999018857.SGD","LU0820561909.HKD","UNH","UNHU","TMED","LU0072461881.USD","FHLC","TRUH","LU2954938101.SGD","RSPH","LU0058720904.USD","LU0976567544.SGD","BK4532","LU1732800096.USD","LU1988902786.USD","LU0158827781.USD","LU0097036916.USD","UNHW","RXD","HRTS","SGXZ51526630.SGD","MHIP","UNHG","LU1153585028.USD","IYH","XBI","LU0965509010.AUD","IHF","LU0310800965.SGD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","IE00B2B36J28.USD","IE00B4R5TH58.HKD","GDOC","GNMX","MEDI","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4585","BK4578","BMED","IBB","IYH","TECB","RSPH","MRNY","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","TBXU","SYNB","MRNX","XLVX","MEDX","FRTY","IE00BJT1NW94.SGD","BK4007","BBP","BK4532","LU0070302665.USD","IDNA","PPH","LU0211331839.USD","LFSC","LABU","BK4588","NVS","NVIB","PINK","IE0009355771.USD","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","PINK","LU0267386448.USD","IEIH","KBWB","MRNX","TECB","BK4504","IAI","LU1244550221.USD","LU2089284900.SGD","LU1791710582.SGD","MEDI","GDOC","NVIB","LU0912757837.SGD","RSPH","BMED","IDNA","LU1720051108.HKD","FRTY","IE00B3S45H60.SGD","GNMX","LU1989772840.SGD","LU0795875169.SGD","LABU","LFSC","LU2023251221.USD","PSCH","SD","SYNB","BK4581","LU0390134368.USD","MRNY","LU2487616109.SGD","LU0210528500.USD","IBB","TBXU","BK4585","XLVX","LU0528227936.USD","LU1668664300.SGD","BBP","LU2264538146.SGD","IYH","LU0106831901.USD","IE00BZ1G4Q59.USD","LU2357305700.SGD","LU1064131342.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673931066","title":"Adherium Secures Non-Dilutive AUD$700,000 Loan to Support Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673931066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673931066?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:59","pubTimestamp":1791323947,"startTime":"0","endTime":"0","summary":"Adherium Ltd. ( ($AU:ADR) ) has issued an announcement. Adherium Limited, a global provider of connected respiratory medical devices and digital he...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adherium-secures-non-dilutive-aud700000-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adherium-secures-non-dilutive-aud700000-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DIVL","ARMH","MDEV","CROC","DINT","FHLC","GDOC","AADR","CVY","XT","IBRN","RSPH","BMED","CURE","MDTX","APIE","HART","IEHS","LNGR","MEDI","HRTS","PINK","SAPH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672710393","title":"Perimeter Medical Imaging AI Adds Veteran CFO Michelle Caron to Board Amid Commercial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672710393","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672710393?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:05","pubTimestamp":1790949909,"startTime":"0","endTime":"0","summary":"Perimeter Medical Imaging AI ( ($TSE:PINK) ) has issued an announcement. Perimeter Medical Imaging AI has appointed seasoned finance executive Mich...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/perimeter-medical-imaging-ai-adds-veteran-cfo-michelle-caron-to-board-amid-commercial-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/perimeter-medical-imaging-ai-adds-veteran-cfo-michelle-caron-to-board-amid-commercial-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTHR","CHAT","AIPO","PINK","AGIX","ARTY","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714670","title":"Press Release: Perimeter Medical Imaging AI Appoints Finance Executive Michelle Caron to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714670","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714670?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944200,"startTime":"0","endTime":"0","summary":"TORONTO and DALLAS, Oct. 2, 2026 /CNW/ -- Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTCQX: PYNKF) (\"Perimeter\" or the \"Company\"), a commercial-stage medical technology company, is pleased to a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","TM","PYNKF","BK4082","ARTY","BK4099","BK4168","BK4555","BK4604","CHAT","PINK","QTOC","AIPO","03160","VTHR","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","PINK","RSPH","NVOX","ELIS","NVOC","NVOH","PJP","ELIL","MEDI","OZEM","JDOC","NBDS","XLVI","LLYX","FXH","CURE","TRUH","IYH","LLII","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","GDOC","BK4596","PSCH","SYNB","BK4566","BK4557","PINK","MRNY","NVIB","BK4007","LU1983299246.USD","BMED","LABU","LFSC","LU2324357040.USD","BK4584","IEIH","TBXU","IBB","IYH","IDNA","BK4588","GNMX","MRNX","BK4585","RSPH","BK4559","FRTY","MEDI","TECB","TEVA","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TBPH","LABU","NVIB","IDNA","LFSC","MEDI","MRNY","GNMX","RSPH","IEIH","FRTY","MRNX","GDOC","TBXU","XLVX","BBP","BK4588","PSCH","PINK","SYNB","IYH","BK4585","BMED","TECB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","TBXU","IEIH","MRNY","IDNA","GDOC","BK4585","XLVX","BK4588","SYNB","NVIB","RSPH","BBP","LFSC","LABU","MRNX","BMED","EES","TECB","FRTY","MEDI","IBB","PINK","PSCH","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","LABU","IEIH","BMED","IDNA","MRNX","IYH","LFSC","BK4585","BK4588","GDOC","IBB","MRNY","XLVX","NVIB","SYNB","BBP","PINK","GNMX","MESO","TBXU","BK4139","PSCH","FRTY","TECB","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147769","title":"Lucid Diagnostics advances Medicare reimbursement and coding infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147769","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147769?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:29","pubTimestamp":1790083753,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) has provided an update. On September 22, 2026, Lucid Diagnostics announced key advances in payment, billing and codin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MHIP","RXD","HCA","TMED","LU1150488135.SGD","JHMH","XLVX","PSCH","BK4551","LU0433182093.SGD","RSPH","SG9999014039.USD","LU1267930490.SGD","PINK","LCIZ","IE00B3S45H60.SGD","BK4099","LNGR","LUCD","REZ","PTH","DVXV","HTEC","IEHS","LU0868494617.USD","XHE","BK4588","LCDL","MHIG","FHLC","LU1084165304.USD","XLVI","IHF","BMED","LU0310800379.SGD","IHI","SG9999014013.SGD","BK4082","TRUH","LU0310799852.SGD","IYH","FXH","MEDI","AGNG","LU0708994859.HKD","IE00B775SV38.USD","LCID","CURE","BK4585","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","BK4588","BK4007","XLVI","VKTX","NVOC","TRUH","PINK","BK4585","BK4599","NBDS","FHLC","THNR","OZEM","BK4539","NVOX","NVOH","IYH","PJP","CURE","LENZ","BK4139","MEDI","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194733778","title":"Weight-Loss Drug Giant Sheds 13,000 Positions","url":"https://stock-news.laohu8.com/highlight/detail?id=1194733778","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194733778?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:30","pubTimestamp":1790004634,"startTime":"0","endTime":"0","summary":"After announcing plans last September to cut 9,000 jobs, Novo Nordisk disclosed the final headcount reduction figures at its Capital Markets Day held in London on September 21.Novo Nordisk stated...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","RSPH","XLVI","NVOH","NVOC","CURE","PINK","MEDI","IYH","NVOX","THNR","NBDS","FHLC","TRUH","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316610","title":"InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669316610?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:00","pubTimestamp":1789995600,"startTime":"0","endTime":"0","summary":"- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365503/0/en/inspiremd-announces-amendments-to-certain-series-j-and-series-k-warrants-providing-potential-gross-proceeds-of-up-to-11-million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BMED","IEIH","SYNB","GNMX","NVIB","PINK","MEDI","BBP","MRNY","BK4585","IDNA","LFSC","MRNX","RSPH","BK4198","BK4588","GDOC","NSPR","PSCH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442151","title":"Ultragenyx price target raised to $35 from $32 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442151?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:10","pubTimestamp":1789981807,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Ultragenyx (RARE) to $35 from $32 and keeps an Overweight rating on the shares following FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-35-from-32-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","PINK","NVIB","PSCH","TBXU","BK4588","IBB","MRNY","SYNB","GDOC","GNMX","BMED","XLVX","LFSC","LABU","IYH","FRTY","RARE","MEDI","TECB","RSPH","BK4139","BBP","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195583160","title":"Health Advisory: Avoid Misusing Weight-Loss Medications, Prioritize Evaluation Before Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1195583160","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195583160?lang=en_us&edition=fundamental","pubTime":"2026-09-19 16:50","pubTimestamp":1789807829,"startTime":"0","endTime":"0","summary":"This is a public service announcement from the local market regulatory authority. All works published on this website that indicate their source or author as relevant government bodies or departments...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","PINK","TRUH","CURE","NVOX","MEDI","NVOH","FXH","PJP","NBDS","XLVI","RSPH","NVOC","FHLC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973580","title":"Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973580","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973580?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:05","pubTimestamp":1789761914,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) “announced that the U.S. Food and Drug Administration has approved its lanreotide injection, 120 mg/0.5 mL, in a ster...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","NVIB","PSCH","TECB","MEDI","BK4007","BK4585","BMED","IEIH","IYH","MRNX","MRNY","SYNB","GNMX","IBB","BBP","LABU","RSPH","BK4588","AMRX","GDOC","TBXU","FRTY","PINK","LFSC","XLVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}]}}